Figure 4From: Discovery and SAR exploration of N-aryl-N-(3-aryl-1,2,4-oxadiazol-5-yl)amines as potential therapeutic agents for prostate cancerCytotoxicity of the most active compounds prepared in this work and digitonin measured on HepG2 (A) and DU-145 (B) cells.Back to article page